Levocarnitine plus myoinositol versus myoinositol alone in women with polycystic ovary syndrome
Compares two supplement treatments for insulin resistance and hormones in women with polycystic ovary syndrome.
Key facts
- Who runs it
- Mst.Sumyara Khatun
- Where
- Dhaka, BangladeshSee the site
- Trial code
- Registry title
- Effect of Levocarnitine Plus Myoinositol Versus Myoinositol Alone on Hormonal and Insulin Resistance in PCOS Women
- Status
- Recruiting
- People taking part
- 72 people, planned
- Started
- 19 Sept 2025
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Myoinositol
- Levo-Carnitine
- Record updated
- 19 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 40 with polycystic ovary syndrome (PCOS), insulin resistance and trouble getting pregnant.
- Age
- 18 to 40 years
- Sex
- Women only
- Disease stage
- PCOS diagnosed by the 2023 international evidence-based guideline criteria, new or old cases. Primary or secondary subfertility.
- Earlier treatment
- Cannot have taken myo-inositol, D-chiro-inositol or insulin-sensitizing drugs such as Metformin or Pioglitazone in the last three months.
- Biomarker or test result
- Insulin resistance, with a HOMA-IR above 2.6.
Main reasons for not taking part
- Hypothyroidism
- Diabetes mellitus
- Known allergy to myo-inositol or levo-carnitine
- Pregnancy
- Treatment with inositol or insulin-sensitizing drugs in the last three months
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age:18-40 years old
- Diagnosed cases of PCOS patients(both old \& new cases) according to International evidence-based guideline criteria 2023
- Primary or secondary subfertility
- Insulin resistance (HOMA-IR >2.6)
Who cannot take part
- Hormonal (Myo-inositol,D-chiro-inositol) or insulin sensitizing drugs like Metformin,Pioglitazone etc. treatment in the last three months
- Diabetes mellitus
- Known hypersensitivity to Myo-inositol and Levo-carnitine
- Hypothyroidism
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Where in Bangladesh
- Bangladesh Medical UniversityDhaka, BangladeshContact: Mst sumiyara khatunNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if combination of levocarnitine and myoinositol works better than myoinositol alone on insulin resistance and hormonal parameters in subfertile women with insulin resistant polycystic ovary syndrome . It will also learn about the safety of drug levocarnitine and myoinositol. The main questions it aims to answer are:
Read full original descriptionShow less
Does combined action of levocarnitine and myoinositol improve insulin resistance and hormonal parameters in comparison to myoinositol alone in subfertile women with insulin resistant polycystic ovary syndrome ? What medical problems do participants have when taking drug levocarnitine and myoinositol? Researchers will compare the drug combination of levocarnitine and myoinositol to myoinositol alone to see if combination therapy works better?
Participants will:
Take drug levocarnitine and myoinositol or a myoinositol alone twice daily for 3 months Visit the clinic once after 3 months for checkups and tests Keep a diary of their symptoms and the number of times.
The 2 groups in the trial
- Experimental arm:( Levocarnitine and myoinositol)Treatment being tested
Participants will receive levocarnitine 330mg and myoinositol 750mg twice daily for 3 months
Treatment: Levo-Carnitine
- Active Comparator (Myoinositol)Existing treatment, for comparison
Participants will receive myoinositol 750mg twice daily for 3 months
Treatment: Myoinositol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effects of Levocarnitine and Myoinositol in Comparison to Myoinositol Alone on Hormonal and Insulin Resistance Parameters in Subfertile Women With Insulin Resistant Polycystic Ovary Syndrome
- Plain-language title
- Levocarnitine plus myoinositol versus myoinositol alone in women with polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07266259, who can take part
- Record updated
- 19 December 2025